CUAMC
RYTM icon

China Universal Asset Management Company’s Rhythm Pharmaceuticals RYTM Stock Holding History

China Universal Asset Management Company’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.21M Sell
10,917
-1,201
-10% -$109K 0.07% 187
2026
Q1 		$1.05M Buy
12,118
+1,243
+11% +$121K 0.08% 184
2025
Q4 		$1.16M Sell
10,875
-767
-7% -$81.4K 0.09% 176
2025
Q3 		$1.18M Sell
11,642
-1,136
-9% -$105K 0.1% 167
2025
Q2 		$807K Buy
12,778
+96
+0.8% +$5.88K 0.08% 191
2025
Q1 		$672K Sell
12,682
-349
-3% -$19.4K 0.06% 216
2024
Q4 		$729K Buy
13,031
+1,273
+11% +$70.3K 0.07% 204
2024
Q3 		$616K Buy
11,758
+4,595
+64% +$220K 0.07% 193
2024
Q2 		$294K Sell
7,163
-4,398
-38% -$176K 0.04% 194
2024
Q1 		$501K Buy
11,561
+4,724
+69% +$207K 0.06% 180
2023
Q4 		$314K Buy
6,837
+5,379
+369% +$170K 0.06% 171
2023
Q3 		$33.4K Buy
1,458
+713
+96% +$16K 0.01% 259
2023
Q2 		$12.3K Sell
745
-18
-2% -$325 ﹤0.01% 307
2023
Q1 		$13.6K Buy
763
+191
+33% +$4.8K ﹤0.01% 257
2022
Q4 		$16.7K Buy
572
+97
+20% +$2.49K 0.01% 186
2022
Q3 		$12K Buy
+475
New +$8.83K 0.01% 188

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

China Universal Asset Management Company's RYTM Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Rhythm Pharmaceuticals (RYTM) stake by 9.9% in Q2 2026, selling an estimated $109K and leaving 10,917 shares worth $1.21M. The position accounts for 0.07% of the portfolio, ranked #187.

China Universal Asset Management Company first reported a position in RYTM in Q3 2022 and has held it in 16 quarters since. 302 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • China Universal Asset Management Company held 10,917 shares of Rhythm Pharmaceuticals worth $1.21M as of Q2 2026.
  • China Universal Asset Management Company sold 1,201 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $109K.
  • Rhythm Pharmaceuticals made up 0.07% of China Universal Asset Management Company's portfolio in Q2 2026, its #187 holding.
  • China Universal Asset Management Company first reported a position in Rhythm Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
  • 302 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.